Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 9/2008

01-09-2008 | Original Research

LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome

Authors: Kenneth Blum, Amanda L. C. Chen, Thomas J. H. Chen, Patrick Rhoades, Thomas J. Prihoda, B. William Downs, Roger L. Waite, Lonna Williams, Eric R. Braverman, Dasha Braverman, Vanessa Arcuri, Mallory Kerner, Seth H. Blum, Tomas Palomo

Published in: Advances in Therapy | Issue 9/2008

Login to get access
Metadata
Title
LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome
Authors
Kenneth Blum
Amanda L. C. Chen
Thomas J. H. Chen
Patrick Rhoades
Thomas J. Prihoda
B. William Downs
Roger L. Waite
Lonna Williams
Eric R. Braverman
Dasha Braverman
Vanessa Arcuri
Mallory Kerner
Seth H. Blum
Tomas Palomo
Publication date
01-09-2008
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 9/2008
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-008-0093-z

Other articles of this Issue 9/2008

Advances in Therapy 9/2008 Go to the issue

Original Research

Prolongation of cardiac allograft survival by syngeneic Hematopoietic stem/progenitor cell transplantation in mice

Original Research

Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes

Original Research

Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis

Case Series

Peritoneal hydatid cyst perforation: a rare cause of emergency abdominal surgeries

Original Research

Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol

Review

Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits